Watchlist Price Alert

Seres Therapeutics Inc. (MCRB)

NASDAQ: MCRB · Real-Time Price · USD

7.90

0.85 (11.98%)

At close: May 12, 2025, 3:59 PM

7.74

-2.03%

Pre-market: May 13, 2025, 04:19 AM EDT

11.98% (1D)

Bid	7.73
Market Cap	68.99M
Revenue (ttm)	n/a
Net Income (ttm)	136K
EPS (ttm)	-16.2
PE Ratio (ttm)	-0.49
Forward PE	-29.38
Analyst	Hold

Ask	8.1
Volume	92,140
Avg. Volume (20D)	73,257
Open	7.15
Previous Close	7.05
Day's Range	7.15 - 8.04
52-Week Range	7.15 - 30.60
Beta	2.88

About MCRB

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol MCRB

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MCRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Seres Therapeutics has released their quartely earnings on May 7, 2025:

Revenue of $0 misses estimates by $16.67M, with NaN% YoY growth.

EPS of 3.75 exceeds estimates by 3.67, with 1488.89% YoY growth.

Why Price Moved

5 days ago

-16.04%

Seres Therapeutics shares are trading lower after ... Unlock content with Pro Subscription

5 months ago

+3.83%

Seres Therapeutics shares are trading higher after the company announced that SER-155 received FDA breakthrough therapy designation for its bloodstream infection reduction.

News

6 days ago · seekingalpha.com

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB ) Q1 2025 Earnings Call May 7, 2025 8:30 AM ET Company Participants Carlo Tanzi - Investor Relations Eric Shaff - President and Chief Executive Officer Marella Th...

3 weeks ago · zacks.com

Down -48.7% in 4 Weeks, Here's Why Seres Therapeutics (MCRB) Looks Ripe for a Turnaround

Seres Therapeutics (MCRB) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings ...

2 months ago · seekingalpha.com

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB ) Q4 2024 Earnings Conference Call March 13, 2025 8:30 AM ET Company Participants Carlo Tanzi - Kendall Investor Relations Eric Shaff - President and Chief Execut...